Unknown

Dataset Information

0

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.


ABSTRACT: The MDM2 and MDMX oncogenes are overexpressed in various types of human cancer and are highly associated with the initiation, progression, metastasis and chemotherapeutic resistance of these diseases, including prostate cancer. The present study was designed to test a natural MDM2 inhibitor, Inulanolide A (InuA), for anti-prostate cancer activity and to determine the underlying mechanism(s) of action. InuA directly bound to the RING domains of both MDM2 and MDMX with high affinity and specificity and disrupted MDM2-MDMX binding, markedly enhancing MDM2 protein degradation. We further discovered that InuA bound to the DNA binding domain of NFAT1, resulting in marked inhibition of MDM2 transcription. InuA inhibited the proliferation, migration, and invasion of prostate cancer cells, regardless of their p53 status and AR responsiveness. Double knockdown of MDM2 and NFAT1 also revealed that the expression of both of these molecules is important for InuA's inhibitory effects on the proliferation and invasion of prostate cancer cells. In summary, InuA represents a novel class of bifunctional MDM2 inhibitors, and should be further investigated as a candidate lead compound for prostate cancer prevention and therapy.

SUBMITTER: Qin JJ 

PROVIDER: S-EPMC5735069 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.

Qin Jiang-Jiang JJ   Li Xin X   Wang Wei W   Zi Xiaolin X   Zhang Ruiwen R  

Frontiers in pharmacology 20171214


The MDM2 and MDMX oncogenes are overexpressed in various types of human cancer and are highly associated with the initiation, progression, metastasis and chemotherapeutic resistance of these diseases, including prostate cancer. The present study was designed to test a natural MDM2 inhibitor, Inulanolide A (InuA), for anti-prostate cancer activity and to determine the underlying mechanism(s) of action. InuA directly bound to the RING domains of both MDM2 and MDMX with high affinity and specificit  ...[more]

Similar Datasets

| S-EPMC4160436 | biostudies-literature
| S-EPMC6650270 | biostudies-literature
| S-EPMC5814211 | biostudies-literature
| S-EPMC3898590 | biostudies-literature
| S-EPMC4472007 | biostudies-literature
| S-EPMC6600429 | biostudies-literature
| S-EPMC4764400 | biostudies-literature
| S-EPMC3129153 | biostudies-literature
| S-EPMC3436289 | biostudies-literature
| S-EPMC10713525 | biostudies-literature